A Sequential Multiple Assignment Randomized Trial Design with Response-Adaptive Tailoring Function
Chen, Z.; Hartman, H.
Show abstract
We present a novel sequential multiple assignment randomized trial (SMART) design that integrates response-adaptive randomization with tailoring functions (RA-TF-SMART). We develop percentile-based and Z-score RA-TFs that incorporate both within-patient and between-patient adaptation to map continuous outcomes to randomization probabilities. We apply Q-learning, tree-based reinforcement learning, and G-estimation to estimate dynamic treatment regimens (DTRs). We compare our RA-TF-SMART designs to balanced randomized SMARTs (BR-SMARTs), tailoring function SMARTs (TF-SMARTs), and generalized outcome-adaptive SMARTs (GO-SMARTs). This study addresses limitations in SMART methodology by presenting designs where randomization probability does not require dichotomization of continuous outcomes and utilizes both individual patient outcomes and accumulated treatment efficacy data from prior participants. RA-TF-SMARTs offer a flexible framework that maximizes benefit for trial participants while maintaining statistical validity for post-trial DTR estimation.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Health Utility Adjusted Survival: a Composite Endpoint for Clinical Trial Designs 95%
- Meta-analysis methods for risk difference: a comparison of different models 92%
- Estimating the Effects of Treatment Regimes over the Course of Chronic Disease: A Multi-state Causal Framework with Baseline Confounding 90%
Similar papers in this journal
- Uncovering interpretable potential confounders in electronic medical records 91%
- Cancer patient survival can be accurately parameterized, revealing time-dependent therapeutic effects and doubling the precision of small trials 91%
- Permutation-based Identification of Important Biomarkers for Complex Diseases via Black-box Models 91%
Similar papers in this journal
- Combination Treatment Optimization Using aPan-Cancer Pathway Model 92%
- Leveraging infectious disease models to interpret randomized controlled trials: controlling enteric pathogen transmission through water, sanitation, and hygiene interventions 91%
- Covasim: an agent-based model of COVID-19 dynamics and interventions 91%
Similar papers in this journal
- Graphing and reporting heterogeneous treatment effects through reference classes 94%
- Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): Statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial 93%
- Machine learning for randomised controlled trials: identifying treatment effect heterogeneity with strict control of type I error 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.